4.7 Article

Quinones and nitroaromatic compounds as subversive substrates of Staphylococcus aureus flavohemoglobin

Journal

FREE RADICAL BIOLOGY AND MEDICINE
Volume 123, Issue -, Pages 107-115

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2018.05.071

Keywords

Flavohemoglobins; Staphylococcus aureus; Quinones; Nitroaromatic compounds; Nitrosative stress

Funding

  1. French Ministere des Affaires Etrangeres [28443UK]
  2. Scientific Council of Lithuania [TAP LZ 07/2013]

Ask authors/readers for more resources

In microorganisms, flavohemoglobins (FHbs) containing FAD and heme (Fe3+, metHb) convert NO. into nitrate at the expense of NADH and O-2. FHbs contribute to bacterial resistance to nitrosative stress. Therefore, inhibition of FHbs functions may decrease the pathogen virulence. We report here a kinetic study of the reduction of quinones and nitroaromatic compounds by S. aureus FHb. We show that this enzyme rapidly reduces quinones and nitroaromatic compounds in a mixed single- and two-electron pathway. The reactivity of nitroaromatics increased upon an increase in their single-electron reduction potential (E-7(1)), whereas the reactivity of quinones poorly depended on their E-7(1) with a strong preference for a 2-hydroxy-1,4-naphthoquinone structure. The reaction followed a 'ping-pong' mechanism. In general, the maximal reaction rates were found lower than the maximal presteady-state rate of FAD reduction by NADH and/or of oxyhemoglobin (HbFe(2+)O(2)) formation (similar to 130 s(-1), pH 7.0, 25 degrees C), indicating that the enzyme turnover is limited by the oxidative half-reaction. The turnover studies showed that quinones prefreqently accept electrons from reduced FAD, and not from HbFe(2+)O(2). These results suggest that quinones and nitroaromatics act as 'subversive substrates' for FHb, and may enhance the cytotoxicity of NO. by formation of superoxide and by diverting the electron flux coming from reduced FAD. Because quinone reduction rate was increased by FHb inhibitors such as econazole, ketoconazole, and miconazole, their combined use may represent a novel chemotherapeutical approach.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available